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Cell migrationa b s t r a c t
FRMD5 is a novel FERM domain-containing protein depicted in tumor progression. However, the
mechanisms underlying FRMD5 inhibition of cell migration is largely unknown. Here, we show that
FRMD5 regulates cell migration by interacting with integrin b5 cytoplasmic tail and ROCK1 in
human lung cancer cells. FRMD5 promotes cell–matrix adhesion and cell spreading on vitronectin,
and thus inhibits cell migration. Furthermore, FRMD5 interacts with ROCK1 and inhibits its activa-
tion that leads to the inhibition of myosin light chain phosphorylation and the actin stress ﬁber for-
mation. Taken together, these ﬁndings demonstrate that the putative tumor suppressive protein
FRMD5 regulates tumor cell motility via a dual pathway involving FRMD5 binding to integrin b5 tail
and to ROCK1.
Structured summary of protein interactions:
integrin B5 binds to FRMD5 by pull down (View interaction) integrin B5 physically interacts with
FRMD5 by pull down (View interaction) FRMD5 physically interacts with integrin B5 by anti tag coim-
munoprecipitation (View interaction) FRMD5 physically interacts with ROCK1 by anti tag coimmunopre-
cipitation (1, 2) ROCK1 physically interacts with FRMD5 by anti bait coip (1, 2) Kindlin-2 physically
interacts with integrin B5 by anti tag coimmunoprecipitation (View interaction) Talin physically inter-
acts with integrin B5 by anti tag coimmunoprecipitation (View interaction)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction and a FERM-associated domain (FA domain). However, theThe protein 4.1R, ezrin, radixin, moesin (FERM) superfamily
consists of over ﬁfty proteins and all members contain a three-
lobed ‘cloverleaf’ structure called FERM domain which binds a
variety of cell-membrane associated proteins and lipids [1]. These
proteins serve as the linker proteins between cell membrane and
the cytoskeleton, and play an important role in the regulation of
cancer cell migration and metastasis [2].
FRMD5 is a FERM domain-containing protein consisting of 570
amino acids. The N-terminal of FRMD5 contains a FERM domainC-terminal of FRMD5 has no obvious domain structure. Little is
known about FRMD5 structurally and functionally. Recently stud-
ies demonstrated that FRMD5 may be involved in metabolic regu-
lation, as FRMD5-WDR76 loci was found associated with altered
serum protein concentrations [3]. In addition, FRMD5 SNPs were
found related with the postprandial chylomicron (CM) triacylglyc-
erol (TG) response [4]. Interestingly, FRMD5 was also found as a
target gene of mutant p53 (R273H) in U251 human glioblastoma
cells in which p53 (R273H) downregulated FRMD5 expression by
binding to intronic and intra-genic sequences of FRMD5, suggest-
ing that FRMD5 may be a suppressive molecule during tumor pro-
gression [5]. We cloned the FRMD5 cDNA and examined the role of
FRMD5 in tumor progression. We found that knockdown of FRMD5
in lung cancer cell H1299 promotes tumor formation in Nude mice.
Furthermore, FRMD5 was found to inhibit the migration and
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behind these functions is largely unknown.
It was known that moderate cell–matrix adhesion and stress
ﬁber formation are needed for cell movement [7]. Cell–matrix
adhesion is mediated by the transmembrane receptors, the inte-
grins, a family of heterodimeric receptors composed of a and b
subunits. Integrins play important roles in the regulation of tumor
migration and invasion [8]. FERM domain-containing proteins
including Talin [9] and Kindlins [10] have been reported to regu-
late integrin activation through directly molecular interaction with
the cytoplasmic tail of integrin b subunit [11].
ROCK1 is a downstream effector of the small GTPase RhoA and
play major roles in a wide range of cellular activities including cell
migration, invasion and metastasis. ROCK1 regulates cell motility
through phosphorylation of the myosin light chain (MLC) and thus
promotes stress ﬁber formation and enhances the capability of cell
motility and migration [12]. In our previous study we found that
FRMD5 interacts with p120-catenin, whereas other group reported
that p120-catenin interacts with ROCK1 [13]. Therefore, there is a
possibility that FRMD5 may also interact with ROCK1 and regulate
the biological function of ROCK1.
In this study, we investigated the association of FRMD5 with
integrin b5 and ROCK1. We identify a new mechanism for regula-
tion of cancer cell migration by showing that FRMD5 coordinates
integrin b5-mediated cell–matrix interaction and ROCK1-con-
trolled actin stress ﬁber formation.
1.1. Plasmids and siRNA
Plasmids of GST-fusion proteins integrin b1, b3 and b5 were
kindly provided by Dr. Staffan Strömblad (Karolinska Institutet,
Sweden). The shRNA expressing plasmid targeting GGAACTGAG
TGGTCAAACA of FRMD5 mRNA was constructed according to the
manufacture protocol of pSUPER RNAi system. FRMD5 small inter-
ference RNA used in this study is si-718 which has the highest
knockdown efﬁciency in the three siRNAs described in [6] and tar-
gets the same site of FRMD5 with shRNA above. An irrelevant con-
trol siRNA was obtained from Qiagen.
The Flag-FRMD5-N-ter and Flag-FRMD5-C-ter were constructed
as described in [6], FRMD5 siRNA/shRNA-resistant mutant and
Flag-FRMD5-DFA plasmid were constructed using Site-directed
Gene Mutagenesis Kit (Beyotime Institute of Biotechnology) as
described by the manufacturer. The MBP-FRMD5-FERM was con-
structed using pMAL-C2X vector (Supplementary Fig. 1A, Table).
1.2. Cell culture
The human lung cancer cell lines, NCI-H1299 and A549, the
human kidney epithelial cell line 293T and green monkey kidney
liver cell line COS-7, were purchased from American Type Culture
Collection. H1299 and A549 cells were cultured in RPMI 1640 med-
ium (Invitrogen), and 293T and COS-7 cells were cultured in DMEM
medium (Invitrogen). All cell culture media were supplemented
with 10% (v/v) FBS (Gibco), penicillin (100 units/ml), and strepto-
mycin (100 lg/ml) (Gibco). Cells were grown at 37 C in humidi-
ﬁed conditions with 5% CO2.
1.3. GST pull-down experiments
GST-b1-tail, GST-b3-tail, GST-b5-tail chimeras, GST proteins and
MBP, MBP-FRMD5-FERM were produced in E. coli BL21 cells. Cells
were induced with 1 mM IPTG for 4 h at 37 C. Bacteria were
harvested and suspended in lysis buffer (PBS, 1% Triton X-100,
1 mM PMSF, 5 mM DTT, and anti-proteases), and sonicated on
ice. GST-fusion or GST proteins were puriﬁed from cleared lysates
by mixing with glutathione-sepharose 4B beads (GE HealthCare),5 ml of cleared lysate/400 ll of beads, for 1 h at 4 C. After exten-
sive washing, the beads were incubated in binding buffer
(50 mM HEPES, pH 7.5, 50 mM NaCl, 0.1% Nonidet P-40 with pro-
tease inhibitor mixture) at 4 C for 1 h with COS-7 cell extracts
overexpressing Flag-FRMD5 or MBP-fusion proteins. Equal
amounts of GST or GST-fusion proteins were used in protein inter-
action experiments. In all cases, after extensive washing, bound
proteins were eluted and analyzed by Western blotting.
1.4. Cell motility assay
Fifteen thousand cells were seeded in 60-mm tissue culture
plates and incubated at 37 C for 6 h. Then dynamics of cell move-
ment was monitored using time-lapse confocal microscopy (Carl
Zeiss LSM780, Germany). Cells were maintained in an incubator
with humidiﬁed air (95%) and 5% CO2 at 37 C. 30 randomly-chosen
cells from experimental group cell line were selected and scanned
sequentially every 30 min for 20 h at 20 magniﬁcation. The
obtained images were converted to video ﬁles using ZEN software.
Cell tracking was followed by Image J software, and the graph was
created using GraphPad Prism 5.
1.5. Adhesion and spreading assay
In a 48-well plate pre-coated with Vitronectin, 5  104 cells/
well were seeded with 300 ll of adhesion buffer (RPMI 1640,
2 mM CaCl2, 1 mMMgCl2, 0.2 mMMnCl2 and 0.5% BSA). Cells were
left to adhere for 2 h at 37 C, and unattached cells were then aspi-
rated. The remaining cells were gently washed three times to
remove unbound cells. The relative number of attached cells was
measured using WST-1 cell viability assay as described previously
[14]. The samples were prepared in triplicates. And three indepen-
dent experiments were analyzed.
For spreading assay, after attachment at 37 C for 2 h as
described above, cells were ﬁxed with 4% formaldehyde for
15 min and typically 15 microscopic ﬁelds were randomly chosen
to be photographed and analyzed.
1.6. Cell migration assay
Transwell chambers (Costar) with 8 lm pore size were used to
perform the cell migration assay. The lower surface of the
Transwell membrane was immersed to 600 ll PBS containing
6 lg/ml Vitronectin. 1  104 H1299 cells or 3  104 A549 cells
were separately seeded on the upper surface of the Transwell
membranes. After 6 h incubation in migration buffer (RPMI 1640,
2 mM CaCl2, 1 mM MgCl2, 0.2 mM MnCl2, and 0.5% bovine serum
albumin) at 37 C in humidiﬁed 5% CO2, the Transwell membranes
were ﬁxed with 4% formaldehyde for 15 min and stained with
Crystal Violet for 10 min. Finally, 15 microscopic ﬁelds were ran-
domly chosen for analyses. Integrin blockade was performed using
monoclonal antibodies directed against avb5-integrins (Chemi-
Con, Rosemont, Illinois), inhibited ROCK1 kinase activity by
Y27632 (EMD/Mil lipore, Billerica, MA). All assays were done in
at least triplicates.
1.7. Co-immunoprecipitation (Co-IP) and Western blotting analysis
Co-IP and Western blotting were performed as described in [6].
The following antibodies: anti-FRMD5 (HPA011746, Sigma–
Aldrich, St. Louis, MO), anti-ROCK1 (ab45171, Abcam, Cambridge,
MA, USA), anti-MLC and anti-P-MLC (3672s and 3675s, Cell
Signaling Technology, Danvers, MA), anti-integrinb5 (D24A5, Cell
Signaling Technology, Danvers, MA), anti-b-actin (TA-09, Zhong-
shan golden bridge, Beijing, China) and anti-MBP (SAB2104172,
4350 J. Hu et al. / FEBS Letters 588 (2014) 4348–4356Sigma–Aldrich, St. Louis, MO) were used to detect the correspond-
ing proteins.
1.8. Immunoﬂuorescence assay
Immunoﬂuorescence for cells was performed as described in
[6]. FITC-labeled phalloidin (1:1000; Invitrogen) was used to visu-
alize ﬁlamentous actin. Hochest 33342 (Sigma–Aldrich, MO, USA)
was used for nuclear staining. And mouse anti-human Flag poly-
clonal antibody was used to stain Flag-FRMD5 (1:100; Sigma–
Aldrich, St. Louis, MO).
2. Results
2.1. Depletion of FRMD5 promotes cell motility
Given that FRMD5 is a membrane associated molecule [6] and it
may involve in cell motility. To this end, we established H1299
cells stably expressing FRMD5-shRNA and FRMD5 was efﬁciently
knocked down in these cells. For determine the speciﬁcity and efﬁ-
cacy of the shRNA, we constructed a FRMD5 mutant (Supplemen-Fig. 1. Downregulation of FRMD5 promotes cell motility. (A) Western bolt was used to
transiently transfected with Flag-FRMD5-WT or Flag-FRMD5-Re. H1299 cells with contr
was performed after the cells were seeded for 6 h. Single cell motility was captured eve
were shown. The displacement (C), distance (D), and velocity (E) of 30 randomly selectetary Fig. 1A, Flag-FRMD5-Re) that resists to the knockdown effect
of siRNA and shRNA of FRMD5 used in this study (Fig. 1A). Western
blot assay shown that the shRNA can knock down exogenous and
endogenous expressed FRMD5, but cannot affect the expression
of FRMD5-Re. Then we examined the role of FRMD5 in the regula-
tion of cell motility using single cell trajectory assay. The trajectory
paths of ten randomly-chosen cells were plotted to one origin for
each experimental group (Fig. 1B). Furthermore, thirty cells were
analyzed for observation of detailed cell motility parameters. We
found that the average of migratory displacement and distance of
cells from the H1299 FRMD5-shRNA group were longer than the
other groups (Fig. 1C and D). Likewise, the average of cell migration
velocity of FRMD5 knockdown group was faster than that of other
groups (Fig. 1E). These results demonstrated that depletion of
FRMD5 promotes cell motility.
2.2. FRMD5 interacts with integrin b5 cytoplasmic tail and is required
for cell–matrix adhesion
A variety of FERM domain-containing proteins are known to
interact with the cytoplasmic tails of integrin b subunit throughdetect the expression of FRMD5. H1299 cells with FRMD5 stably knockdown were
ol shRNA were transfected with Flag vector as control. (B) Single cell tracking assay
ry 30 min for 20 at 37 C under 5% CO2 atmosphere. Paths of 10 cells of each group
d cells were analyzed by one way ANOVA assay, ⁄P < 0.05, ⁄⁄P < 0.01. ⁄⁄⁄P < 0.001.
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can interact with integrin. In a GST pull-down assay we found that
FRMD5 could be pulled down by GST-b5 tail but not integrin b1 or
integrin b3 tails (Fig. 2A). This interaction was further conﬁrmed in
a co-IP assay using A549 cell lysate transiently transfected with
Flag-FRMD5, and the result showed that endogenous integrin b5
interacts with FRMD5 (Fig. 2B). For answer if the interaction
between FRMD5 and integrins is a direct one, GST and GST-b5 tail
were used to pull down MBP-tagged FERM domain of FRMD5Fig. 2. FRMD5 strengthen cell–matrix adhesion via interaction with integrin b5. RMD5 i
and b5 subunits were used to pull down Flag-FRMD5 in COS-7 cells, and only integrin b5 w
for 48 h. Then co-IP was carried out using an anti-Flag antibody. Immunoprecipitates wer
(C) GST and GST-integrin b5 cytoplasmic tail were used to pull downMBP-FRMD5-FERM e
in Western blot assay. (D) FRMD5 promotes cell spreading on VN. ⁄P < 0.05, ⁄⁄⁄P < 0.001
⁄⁄P < 0.01. (F) Western blot shown that downregulation or overexpression of FRMD5 can
interaction of Kindlin-2 with integrin b5. (H) FRMD5 inhibits Talin head interaction witexpressed in bacteria. We found that MBP-FRMD5-FERM can be
pulled down by GST-b5 tail but not GST, indicating that FRMD5
can directly interact with integrin b5 (Fig. 2C). Since integrin
avb5 mainly mediates cell attachment and migration on Vitronec-
tin (VN), we then examined the effect of FRMD5 on cell spreading
and attachment in H1299 cells. H1299 cells were plated onto cov-
erslides pre-coated with VN and cell spreading was examined.
The results demonstrated that FRMD5 knockdown greatly affected
cell spreading (Fig. 2D and E for quantiﬁcation) and attachmentnteracts with integrin b5. (A) GST and GST-fusion cytoplasmic tail of integrin b1, b3
as found to interact with FRMD5. (B) A549 cells were transfected with Flag-FRMD5
e probed using an anti-FRMD5 antibody and an anti-integrin b5 antibody separately.
xpressed in bacterial. Anti-MBP antibody was used to detect the MBP-fusion protein
, bar = 100 lm. (E) Knockdown of FRMD5 by siRNA inhibits cell attachment on VN.
not change integrin b5 expression. (G) Co-IP assay shown that FRMD5 promotes the
h integrin b5 in a co-IP assay.
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cell attachment to VN, and FRMD5 is required for integrin avb5-
mediated cell–matrix adhesion on VN. However, downregulation
or upregulation of FRMD5 do not inﬂuence the protein level of inte-
grin b5 (Fig. 2G). It is known that Talin and Kindlin family members
are FERM domain-containing proteins, and they all bind to the
integrin b cytoplasmic tails. Therefore, it is of interest to examine
if FRMD5 affects the binding of Kindlin or Talin with integrinFig. 3. FRMD5 interacts with ROCK1 without affecting the expression of ROCK1. (A) ROCK
shRNA or con-shRNA, or H1299 cells transiently transfected with Flag or Flag-FRMD5 vec
performed with an anti-Flag mAb. FRMD5 and ROCK1 were detect using an anti-FRMD5
FRMD5 interact with ROCK1 in H1299 cells in co-IP assay. (E and F) Different FRMD5 c
FRMD5 was found necessary for FRMD5-ROCK1 interaction.b cytoplasmic tails. To this end, we co-transfected 293T cells with
GFP-FRMD5, Flag-Kindlin-2 and pcDNA3.0-b5 integrin or co-trans-
fected 293T cells with GFP-FRMD5, Flag-Talin-Head and pCDNA3.0-
b5, we then performed a co-IP assay and found that FRMD5 pro-
moted Kindlin 2 interactionwith integrin b5 but inhibited the inter-
action between Talin head and integrin b5 (Fig. 2H and I). These
ﬁndings indicated that FRMD5 interferes with the interaction of
integrin b cytoplasmic tails with their binding partners.1 expression was detected by Western blot in H1299 cells stably expressing FRMD5
tors. (B) 293T cells were transfected with Flag or Flag-FRMD5 vectors, then co-IP was
Ab and an anti-ROCK1 Ab. (C and D) Both endogenous FRMD5 and exogenous Flag-
onstructs were cloned to determine the FRMD5-ROCK1 binding site. FA domain of
Fig. 4. FRMD5 inhibits the formation of stress ﬁber by suppressing ROCK1 activity. (A) A549 cells were transfected with Flag or Flag-FRMD5 expression vectors for 48 h.
Before Western blot analysis cells were treated with DMSO or Y27632 for 1 h. The expression of related proteins was detected by Western blot using indicated antibodies. (B)
H1299 cells stably expressing FRMD5 shRNA or control shRNA were used to detect the expression of p-MLC after treated with Y27632 or DMSO as described above. (C) A549
cells were transiently transfected with Flag-FRMD5 for 48 h, then the cells were ﬁxed and F-actin was stained by FITC-Phalloidine (Green), FRMD5 was stained using an anti-
Flag antibody (red), and the nuclei (blue) were stained by Hoechst 33342, bar = 50 nm. (D) H1299 cells were transiently transfected with FRMD5 siRNA or control siRNA for
72 h. Western blot was then performed to detect the expression of FRMD5. (E) Immunoﬂuorescence was carried out to detect the stress ﬁber rearrangement as above, F-actin
were stained by FITC-Phalloidine and the nuclei were stained by Hoechst 33342, bar = 50 nm.
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It is known that reorganization of actin cytoskeleton is a
prerequisite for cell motility. ROCK1 is the major effector of a small
GTPase RhoA, and a key molecule that regulates stress ﬁber forma-
tion during cell migration. The downstream protein and substrate
of ROCK1 is myosin light chain, which can be phosphorylated by
ROCK1 at Ser-19. Phosphorylated ROCK1 induces actin polymeriza-
tion and provide tension needed for cell movement [17].
In addition, ROCK1 has been reported as a candidate p120 bind-
ing partner that recruits ROCK1 and is correlated tightly with AJ
integrity [13]. Given that our previous study demonstrated that
FRMD5 interacts with p120-catenin and co-localizes with several
adherent junction molecules [6], we therefore examined if FRMD5
affects the expression of ROCK1 or associates with ROCK1 in
H1299 cells to regulate cellmotility. Our results showed that ROCK1
expressionwasnot changed either by knockdownor overexpressionFig. 5. FRMD5 inhibits tumor cell migration. (A) A549 cells were transfected with Flag o
with IgG or avb5 speciﬁc blocking antibody (50 lg/ml) for 0.5 h, then the cells were adde
was add to the lower-chamber. 6 h later, the cells migrated were ﬁxed and stained by c
48 h, then treated the cells with Y27632 (10 lM) for 1 h. Next the cells were harvested an
enhances cell migration.1  104 H1299 cells stably expressing FRMD5 shRNA or con s
functional blocking antibody (C) or Y27632 (D), respectively. Student’s t-test was used iof FRMD5 (Fig. 3A). Interestingly, we found that ROCK1 interacts
with exogenous FRMD5 (Fig. 3B and D) as well as endogenous
ROCK1 (Fig. 3C) in 293T and H1299 cells in co-IP assays.
To determine the binding region between FRMD5 and ROCK1, a
panel of FRMD5 deletion mutants were constructed (Fig. 3E). Then
a co-IP assay was performed and ROCK1 was found not interact
with FRMD5 without the FA domain (Fig. 3F), suggesting that the
FA domain is required for the interaction between FRMD5 and
ROCK1. We also noted that the N-terminal of FRMD5 has a higher
ability to associate with ROCK1 than the full-length FRMD5 (Fig. 3F
left panel). These data indicated that FRMD5 interacts with ROCK1
through its FA domain with the ROCK1N-terminal domain.
2.4. FRMD5 inhibits ROCK1 activity and stress ﬁber formation
Aforementioned data indicated that FRMD5 interacts with
ROCK1. Therefore, it is of interest to know if this interaction affectsr Flag-FRMD5 vectors, respectively. After 48 h, cells were harvested and pre-treated
d to the upper chamber of Transwell (3  104 cells/well), and vitronectin (50 ng/ml)
rystal violet. (B) A549 cells transfected with Flag or Flag-FRMD5, respectively, after
d counted, migration assay was performed as in A. (C, D) Downregulation of FRMD5
hRNA were used to for migration assay as described above, treated the cells with
n the statistical analyses (⁄P < 0.05, ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001).
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as a downstreammolecule of ROCK1, which regulates cell motility.
Phosphorylation of MLC is an indicator of ROCK1 activity. To this
end, we examined the effect of FRMD5 on MLC phosphorylation.
Endogenous FRMD5 was stably knocked down in H1299 cells with
FRMD5 shRNA expression vector, whereas Flag-FRMD5 was over-
expressed in A549 cells transiently transfected with Flag-FRMD5
expression vector. An antibody that speciﬁcally recognizes the
Ser-19 phosphorylation of MLC (p-MLC) was used to measure the
ROCK1 activity. Our data indicated that knockdown of FRMD5
leads to increased phosphorylation of MLC (Fig. 4A upper and
down panels), an indication of ROCK1 activation. On the contrary,
overexpression of FRMD5 inhibited the phosphorylation of MLC
(Fig. 4B upper and down panels). To ensure that the MLC phosphor-
ylation was caused by ROCK1 kinase activity, we applied a ROCK1
speciﬁc inhibitor Y27632. As seen in Fig. 4A and B, the ROCK1
kinase activity was speciﬁcally blocked by Y27632. These data
indicated that FRMD5 is a novel regulator of ROCK1 kinase activity.
Meanwhile the possible role of FRMD5 on stress ﬁber formation
was also examined. As shown in Fig. 4C, overexpression of FRMD5
apparently inhibited stress ﬁber formation (as indicated by arrow),
whereas the FRMD5 non-expressed cells displayed strong actin-
based stress ﬁber. On the opposite, knockdown of endogenous
FRMD5 expression by siRNA enhanced stress ﬁber formation in
H1299 cells transfected with FRMD5 siRNA (Fig. 4D and E,
arrowed). Collectively, these data indicated that FRMD5 suppresses
actin stress ﬁber formation by inhibition of ROCK1 kinase activity
in cells.
2.5. FRMD5 regulates tumor cell migration by controlling the activity
of ROCK1 and integrin b5 – matrix interaction
Given that FRMD5 interacts with integrin b5 and ROCK1 and
regulates integrin-mediated cell–matrix adhesion and ROCK1-
regulated actin polymerization, and inhibits cell migration (Sup-
plementary Fig. 1B). To uncover the role of FRMD5 in tumor cell
migration, in a gain of function experiment A549 cells were tran-
siently transfected with Flag-FRMD5 expression vector controlled
by an empty vector. After 48 h, cells were treated separately with
integrin avb5 speciﬁc blocking antibody or ROCK1 inhibitor
Y27632 for 0.5 h. Cell migration assays were then performed. As
shown in Fig. 5A and B, overexpression of FRMD5 led to a
decrease in cell migration. Importantly, the migratory ability of
cells overexpressing Flag-FRMD5 or the control vector can be
further inhibited by addition of an integrin avb5 functional block-
ing antibody (Fig. 5A upper and lower panels) or ROCK1 inhibitor
Y27632 (Fig. 5B upper and lower panels) (P < 0.01). These data
suggested that FRMD5 interacts with both integrin avb5-
mediated and ROCK1-dependent processes to regulate cancer cell
migration. Furthermore, in a loss of function experiment H1299
cells stably transfected with FRMD5-shRNA and the control vector
were assayed for cell migration with or without integrin avb5
functional blocking antibody or ROCK1 inhibitor Y27632. As
shown in Fig. 5C and D, we found that knockdown of endogenous
FRMD5 by shRNA signiﬁcantly promoted cell migration compared
with the control (P < 0.001). However, the promoted effects by
FRMD5 knockdown can be obviously reversed by avb5 functional
blocking antibody or ROCK1 inhibitor Y27632 (P < 0.001). Inter-
estingly, the cell migratory abilities in the control groups were
only slightly reduced upon addition of avb5 functional blocking
antibody or ROCK1 inhibitor Y27632, suggesting that FRMD5
plays an important role in integrin avb5 and ROCK1 regulated
cancer cell migration. Taken together, these ﬁndings indicated
that FRMD5 inhibits tumor cell migration through controlling
integrin avb5-mediated cell–matrix interaction and ROCK1 kinase
activity.3. Discussion
Integrins play important roles in tumor cell migration and inva-
sion. It was reported that expression of integrin avb5 is highly
related with histological subtypes, TNM stages and lymph node
metastases of lung cancer [18]. Abnormal activation of integrin
avb5 was also reported in other types of cancer. Thus, targeting
integrins is considered very promising in cancer therapy [19,20].
In this study, we identify a new function of FRMD5 by showing that
FRMD5 regulates lung cancer cell migration. We here demon-
strated for ﬁrst time that FRMD5 interacted with integrin b5 cyto-
plasmic tail. This FRMD5 – integrin b5 interaction may stabilize
cell–matrix structure and limits cell movement.
A variety of FERM domain-containing proteins including Talin,
Kindlins and FAK have been found to interact and regulate inte-
grin-mediated cellular functions [21]. Integrin b5 associates with
Talin at the membrane proximal NPxY motif and Kindlins at the
distal NXXY motif [22]. Therefore, identifying the site that FRMD5
binding to integrin is important for understanding the role of
FRMD5 in integrin-mediated cellular functions. In the present
study we made an important observation that FRMD5 promotes
interaction between Kindlin2 and integrin b5 while inhibits Talin
association with integrin b5. To look at the structure basis of this
observation, we analyzed the 3D structure of integrin b3-talin chi-
mera using Phyre2 (Supplementary data) and found that FRMD5
FERM domain has a similarity with the crystal structure of integrin
b3-talin chimera, so we considered that FRMD5 inﬂuences integrin
activation by competing with Talin in binding integrin b cytoplas-
mic tail, affecting the inside-out signal transduction, then enhances
cell adhesion and promotes cell spreading on extracellular matrix,
accordingly limits cell movement. However, molecular detail of
FRMD5 promotion of Kindlin2 interaction with integrin b5 is an
interesting topic and worthy of further study.
In addition, we did not show a direct interaction between
FRMD5 and actin (Supplementary Fig 1C). However, we did ﬁnd
that FRMD5 regulates actin-based cytoskeletal rearrangements
by modulating the kinase activity of ROCK1. It was known that a
variety of proteins and microRNAs regulates tumor invasion and
metastasis through control of ROCK1 expression or its kinase activ-
ity [23–25]. The ROCK1 composed of three parts, the N-terminal
catalytic domain, the C-terminal Rho-binding domain, and the cen-
tral coiled-coil region. As a serine/threonine kinase, ROCK1 can be
activated by a variety of molecules including small GTPases. For
example, Rho A associates with the C-terminal of ROCK1 and
enhances its kinase activity [7]. However, Rho E inhibits the activa-
tion of ROCK1 by binding to its kinase domain [26]. Meanwhile,
Rho E can also be phosphorylated by ROCK1 at several sites. In this
study, we demonstrated for the ﬁrst time that the FERM domain-
containing protein FRMD5 interacts with ROCK1 through the FA
domain of FRMD5, and inhibits ROCK1 kinase activity without
affecting the protein level of ROCK1. We therefore presumed that
the FRMD5-FA domain may contain putative phosphorylation sites
of ROCK1 considering the fact that other FERM domain-containing
proteins can be phosphorylated at the similar FA region by AGC
protein kinase family [27]. In fact, ROCK1 do phosphorylates some
of the FERM domain-containing proteins [28]. Therefore, ROCK1
phosphorylation of FRMD5-FA remains an interesting question
for future experiment. The structure of FA domain modeled using
Phyre2 displayed one sole a helix (residues 321–333) in FRMD5.
On the other hand, the coiled-coil region of ROCK1 has a hinge that
is a target binding site of ROCK1 inhibitor [29]. Based on structural
analysis we predict that the hinge might be the region that binds to
the a helix of FRMD5-FA domain. However, this hypothesis
requires further investigations to conﬁrm. Furthermore, the mech-
anism accounting for FRMD5 inhibition of ROCK1 activation is
unclear and warrants further investigations.
4356 J. Hu et al. / FEBS Letters 588 (2014) 4348–4356Both ROCK1 and integrin avb5 regulates cell attachment and
cytoskeletal rearrangements, suggesting that there is a functional
overlapping between ROCK1 and integrin avb5. However, before
this report there is no indication on how ROCK1 and integrin
avb5 coordinate to regulate cell migration. Therefore, this report
may represent an interpretation on the functional coordination
between integrin avb5 and ROCK1.
In conclusion, putative tumor suppressive protein FRMD5
inhibits tumor cell migration through binding with integrin avb5
to regulate cell–matrix interaction and inhibition of ROCK1 kinase
activity to control actin stress ﬁber formation. This way FRMD5
may play a tumor suppressive role in cancer progression.
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